MIMI OLIFF: Open Payments
NPI 1568772093 · WEST ORANGE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,834 in 144 payments from 22 companies in 2025. Trend: 2023 $1,683 · 2024 $2,820 · 2025 $2,834
Food & beverage: $2,712Education: $123
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 19 | $503 |
| ABBVIE INC. | 28 | $502 |
| Regeneron Healthcare Solutions, Inc. | 14 | $294 |
| Galderma Laboratories, L.P. | 11 | $267 |
| Arcutis Biotherapeutics, Inc. | 13 | $198 |
| PFIZER INC. | 10 | $164 |
| Amgen Inc. | 8 | $136 |
| UCB, Inc. | 7 | $125 |
| Novartis Pharmaceuticals Corporation | 5 | $123 |
| Botanix SB Inc | 6 | $110 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, NEMLUVIO, RINVOQ, Zoryve, Otezla, Bimzelx.
Industry payments across NJ — which companies pay providers there.
